MetLife Investment Management’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Buy |
10,940
+3,281
| +43% | +$96.2K | ﹤0.01% | 1918 |
|
|
2025
Q1 | $197K | Sell |
7,659
-13
| -0.2% | -$334 | ﹤0.01% | 2211 |
|
|
2024
Q4 | $221K | Hold |
7,672
| – | – | ﹤0.01% | 2255 |
|
|
2024
Q3 | $182K | Buy |
+7,672
| New | +$182K | ﹤0.01% | 2334 |
|
|
2022
Q2 | – | Sell |
-2,878
| Closed | -$103K | – | 2912 |
|
|
2022
Q1 | $103K | Buy |
+2,878
| New | +$103K | ﹤0.01% | 2619 |
|
|
2021
Q4 | – | Sell |
-980
| Closed | -$112K | – | 2560 |
|
|
2021
Q3 | $112K | Buy |
+980
| New | +$112K | ﹤0.01% | 2392 |
|